# Sandoz Incorporated – FDA Inspection, Apr 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/sandoz-incorporated/1753bbcb-38cd-4266-b013-2cf283d256a3
Source feed: FDA_Inspections

> FDA inspection 1087173 of Sandoz Incorporated, April 16, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087173
- Company Name: Sandoz Incorporated
- Inspection Date: 2019-04-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1013036 - 2017-03-29
- FDA Inspection 981954 - 2015-10-30
- [FDA Inspection 853190 - 2013-10-17](https://www.keypedia.com/records/fda_inspections/sandoz-incorporated/365d2763-8443-4d1e-947f-7ef720539d48)
- FDA Inspection 797878 - 2012-08-14
- [FDA Inspection 727431 - 2011-05-06](https://www.keypedia.com/records/fda_inspections/sandoz-incorporated/76190733-de22-4e05-b24c-1e0b27130dc0)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/erika-v-butler/3e654530-4c29-403d-880e-a5422315c3c0)

Company: https://www.keypedia.com/companies/sandoz-incorporated/6aa8ae0e-b0f0-49a7-a584-c6e6796c6481

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c